ADA Interactive Webinar :FDA's Gluten-Free Rulemaking: Implications for Your Clients with Celiac Disease

 
Thursday, December 8, 2011
2 p.m. to 3:30 p.m. (Eastern)
1 p.m. to 2:30 p.m. (Central)
11 a.m. to 12:30 p.m. (Pacific)
How will FDA's proposed gluten-free food labeling impact your clients with celiac disease?  Results from a recent web-administered FDA survey and experimental study that focused on gluten-free diet-related issues will be presented. An overview of the major legislative and other activities that led up to FDA's gluten-free food labeling rulemaking and the resulting proposed requirements for a food labeled gluten-free marketed in the U.S. will be described.
Objectives

• Communicate the beliefs, preferences, and behaviors of adults with celiac disease and adults with non-celiac gluten sensitivities about how "gluten-free" is expressed on the food label.
• Describe the FDA proposed criteria for defining the food labeling term "gluten-free."
• State some of the factors that FDA will consider in developing a final rule on gluten-free food labeling.
• Discuss education on food label reading, including gluten-free claims, may contain statements, and cross contamination.

Presenters

• Linda Verrill, PhD
  Social Scientist, Center for Food Safety and Applied Nutrition, US Food & Drug Administration; College Park, Maryland
• Rhonda R. Kane, MS, RD
  Consumer Safety Officer, FDA; College Park, Maryland
• Tricia Thompson, MS, RD
  Nutrition Consultant-Celiac Disease; Manchester, Massachusetts

For More Details or to register go to
http://www.eatright.org/pd/glutenfree/

ADA webinar:
FDA's Gluten-Free Rulemaking: Implications for Your Clients with Celiac Disease